Bicycle Therapeutics Plc. (BCYC) NASDAQ

$22.30 (0.20) (-0.89%)

Market Cap: $475.10M

As of 04/12/24 04:00 PM EDT. Market closed.

(BCYC)

Bicycle Therapeutics Plc. (BCYC)
NASDAQ

$22.30
(0.20) (-0.89%)

Market Cap: $475.10M

As of 04/12/24 04:00 PM EDT. Market closed.

Add to Portfolio

bicycle therapeutics is a biotechnology company with big ambitions. we aim to revolutionise the pharmaceutical landscape with our disruptive technology and proprietary bicyclic peptide (bicycle®) product platform and to develop transformational new therapies for patients to improve future treatment options in oncology. bicycles, a new class of small molecular weight drug conjugates for oncology ... read more

bicycle therapeutics is a biotechnology company with big ambitions. we aim to revolutionise the pharmaceutical landscape with our disruptive technology and proprietary bicyclic peptide (bicycle®) product platform and to develop transformational new therapies for patients to improve future treatment options in oncology. bicycles, a new class of small molecular weight drug conjugates for oncology and other diseases, are designed to have superior targeting abilities and to be more efficacious and better tolerated than existing drug conjugate modalities. they combine the properties of several therapeutic entities in a single modality, exhibiting the affinity and selective pharmacology associated with antibodies; the distribution kinetics of small molecules, allowing rapid tumor penetration; and the “tuneable” pharmacokinetic half-life and renal clearance of peptides, sparing cytotoxin-payload derived liver and gastrointestinal toxicity. our unique ip is based on the work of scientific foun read less

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
CEO
Kevin Lee
Full Time Employees
224
URL
Address
Babraham Hall, B900, Cambridgeshire, Cambridge, CB22 3AT.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
CEO
Kevin Lee
Full Time Employees
224
Address
Babraham Hall, B900, Cambridgeshire, Cambridge, CB22 3AT.
PRICE CHART FOR BICYCLE THERAPEUTICS PLC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$22.43
Previous Close
$22.50
Days Range
$22.16 - $22.99
52 week range
$12.54 - $28.91
Volume
221,426
Avg. Volume (30 days)
436,722
Market Cap
$475.10M
Dividend Yield
-
P/E
(2.63)
Shares Outstanding
21,304,801
Open
$22.43
Previous Close
$22.50
Days Range
$22.16 - $22.99
52 week range
$12.54 - $28.91
Volume
221,426
Avg. Volume (30 days)
436,722
Market Cap
$475.10M
Dividend Yield
-
P/E
(2.63)
Shares Outstanding
21,304,801
FINANCIAL STATEMENTS FOR BICYCLE THERAPEUTICS PLC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR BICYCLE THERAPEUTICS PLC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFFApr 11, 2024 Sale$22.492575,78022,891Apr 12, 2024, 04:30 PM
Lee KevinCHIEF EXECUTIVE OFFICERApr 03, 2024 Sale$23.813,15875,192387,270Apr 05, 2024, 04:30 PM
Skynner MichaelCHIEF TECHNOLOGY OFFICERApr 03, 2024 Sale$23.8195522,73994,884Apr 05, 2024, 04:30 PM
Milnes AlistairCHIEF OPERATING OFFICERApr 03, 2024 Sale$23.8195522,73972,241Apr 05, 2024, 04:30 PM
Keen NicholasCHIEF SCIENTIFIC OFFICERApr 03, 2024 Sale$23.8179018,81062,803Apr 05, 2024, 04:30 PM
Crockett NigelCHIEF BUSINESS OFFICERApr 03, 2024 Sale$23.8195522,73947,761Apr 05, 2024, 04:30 PM
Thompson Travis AlvinCHIEF ACCOUNTING OFFICERApr 03, 2024 Sale$23.811523,61923,223Apr 05, 2024, 04:30 PM
Thompson Travis AlvinChief Accounting OfficerJan 03, 2024 Sale$17.5060410,57023,375Jan 04, 2024, 06:36 PM
Keen NicholasChief Scientific OfficerJan 03, 2024 Sale$17.502,64046,20063,593Jan 04, 2024, 06:34 PM
Crockett NigelChief Business OfficerJan 03, 2024 Sale$17.502,64346,25348,716Jan 04, 2024, 06:28 PM
Milnes AlistairChief Operating OfficerJan 03, 2024 Sale$17.502,64346,25373,196Jan 04, 2024, 06:27 PM
Skynner MichaelChief Technology OfficerJan 03, 2024 Sale$17.502,64346,25395,839Jan 04, 2024, 06:26 PM
Lee KevinChief Executive OfficerJan 03, 2024 Sale$17.508,703152,303390,428Jan 04, 2024, 06:25 PM
Thompson Travis AlvinChief Accounting OfficerOct 03, 2023 Sale$20.00541,0807,979Oct 05, 2023, 05:50 PM
Keen NicholasChief Scientific OfficerOct 03, 2023 Sale$20.002725,44038,233Oct 05, 2023, 05:49 PM
Crockett NigelChief Business OfficerOct 03, 2023 Sale$20.004428,84029,359Oct 05, 2023, 05:48 PM
Milnes AlistairChief Operating OfficerOct 03, 2023 Sale$20.004428,84036,839Oct 05, 2023, 05:47 PM
Lee KevinChief Executive OfficerOct 03, 2023 Sale$20.001,47029,400322,131Oct 05, 2023, 05:46 PM
Skynner MichaelChief Technology OfficerOct 03, 2023 Sale$20.004428,84070,482Oct 05, 2023, 05:46 PM
Thompson Travis AlvinChief Accounting OfficerJul 03, 2023 Sale$25.10611,5318,033Jul 06, 2023, 04:57 PM
Skynner MichaelChief Technology OfficerJul 03, 2023 Sale$25.1045111,32070,924Jul 06, 2023, 04:53 PM
Milnes AlistairChief Operating OfficerJul 03, 2023 Sale$25.1045111,32037,281Jul 06, 2023, 04:52 PM
Lee KevinChief Executive OfficerJul 03, 2023 Sale$25.101,49837,600323,601Jul 06, 2023, 04:51 PM
Keen NicholasChief Scientific OfficerJul 03, 2023 Sale$25.103368,43438,505Jul 06, 2023, 04:50 PM
Crockett NigelChief Business OfficerJul 03, 2023 Sale$25.1045111,32029,801Jul 06, 2023, 04:49 PM
Keen NicholasChief Scientific OfficerApr 03, 2023 Sale$21.113196,73438,841Apr 05, 2023, 04:43 PM
Skynner MichaelChief Technology OfficerApr 03, 2023 Sale$21.114479,43671,375Apr 05, 2023, 04:43 PM
Milnes AlistairChief Operating OfficerApr 03, 2023 Sale$21.114479,43637,732Apr 05, 2023, 04:42 PM
Kalowski LeePresident and CFOApr 03, 2023 Sale$21.113767,93730,309Apr 05, 2023, 04:41 PM
Crockett NigelChief Business OfficerApr 03, 2023 Sale$21.114479,43630,252Apr 05, 2023, 04:40 PM
Lee KevinChief Executive OfficerApr 03, 2023 Sale$21.111,48631,369325,099Apr 05, 2023, 04:39 PM
Crockett NigelChief Business OfficerJan 03, 2023 Sale$29.061,80152,33730,699Jan 05, 2023, 09:21 PM
Milnes AlistairChief Operating OfficerJan 03, 2023 Sale$29.061,80152,33738,179Jan 05, 2023, 09:19 PM
Smethurst DominicChief Medical OfficerJan 03, 2023 Sale$29.061,80152,33736,699Jan 05, 2023, 09:18 PM
Skynner MichaelChief Technology OfficerJan 03, 2023 Sale$29.061,80152,33771,822Jan 05, 2023, 09:16 PM
Keen NicholasChief Scientific OfficerJan 03, 2023 Sale$29.061,81752,80239,160Jan 05, 2023, 09:14 PM
Kalowski LeePresident and CFOJan 03, 2023 Sale$29.061,81552,74430,685Jan 05, 2023, 09:12 PM
Lee KevinChief Executive OfficerJan 03, 2023 Sale$29.066,000174,360326,585Jan 05, 2023, 09:06 PM
Milnes AlistairChief Operating OfficerMar 25, 2022 Option Exercise$20.125,155103,71922,480Mar 29, 2022, 04:36 PM
Keen NicholasChief Scientific OfficerDec 21, 2021 Option Exercise$14.0015,477216,67815,477Dec 22, 2021, 09:01 PM
Legault PierreDirectorDec 22, 2021 Option Exercise$8.4897,860829,85397,860Dec 22, 2021, 09:00 PM
Legault PierreDirectorDec 21, 2021 Option Exercise$8.4444,537375,89244,537Dec 22, 2021, 09:00 PM
Legault PierreDirectorDec 20, 2021 Option Exercise$8.417,60363,9417,603Dec 22, 2021, 09:00 PM
Legault PierreDirectorDec 21, 2021 Sale$57.1144,5372,543,5080Dec 22, 2021, 09:00 PM
Legault PierreDirectorDec 20, 2021 Sale$57.027,603433,5230Dec 22, 2021, 09:00 PM
Legault PierreDirectorDec 22, 2021 Sale$58.0197,8605,676,8580Dec 22, 2021, 09:00 PM
Lee KevinChief Executive OfficerOct 18, 2021 Sale$60.00492,940225,085Oct 18, 2021, 06:22 PM
Lee KevinChief Executive OfficerOct 15, 2021 Sale$60.0532019,216225,134Oct 18, 2021, 06:22 PM
Lee KevinChief Executive OfficerOct 14, 2021 Sale$60.004,631277,860225,454Oct 18, 2021, 06:22 PM
Lee KevinChief Executive OfficerOct 11, 2021 Sale$53.885,000269,388230,683Oct 13, 2021, 05:28 PM
Keen NicholasChief Scientific OfficerOct 05, 2021 Sale$45.102,17898,2280Oct 05, 2021, 04:16 PM
Keen NicholasChief Scientific OfficerOct 01, 2021 Sale$45.001,18853,4602,178Oct 05, 2021, 04:16 PM
Smethurst DominicChief Medical OfficerSep 23, 2021 Option Exercise$18.556,000111,3006,000Sep 27, 2021, 04:53 PM
Keen NicholasChief Scientific OfficerSep 16, 2021 Sale$45.011,95587,9953,366Sep 17, 2021, 04:47 PM
Keen NicholasChief Scientific OfficerSep 15, 2021 Sale$45.003,000135,0005,321Sep 17, 2021, 04:47 PM
Kalowski LeePresident and CFOSep 02, 2021 Option Exercise$9.8210,00098,20010,000Sep 03, 2021, 04:49 PM
Kalowski LeePresident and CFOSep 02, 2021 Sale$40.0010,000400,0000Sep 03, 2021, 04:49 PM
Keen NicholasChief Scientific OfficerSep 02, 2021 Sale$40.0010,000400,0008,321Sep 03, 2021, 04:47 PM
Lee KevinChief Executive OfficerSep 01, 2021 Option Exercise$14.0022,890320,460267,170Sep 03, 2021, 04:46 PM
Lee KevinChief Executive OfficerSep 01, 2021 Sale$37.2127,0851,007,897258,979Sep 03, 2021, 04:46 PM
Lee KevinChief Executive OfficerSep 02, 2021 Sale$40.005,000200,000235,085Sep 03, 2021, 04:46 PM
Lee KevinChief Executive OfficerAug 31, 2021 Option Exercise$14.0010,420145,880255,505Aug 31, 2021, 05:29 PM
Lee KevinChief Executive OfficerAug 27, 2021 Option Exercise$14.001,80825,312246,893Aug 31, 2021, 05:29 PM
Lee KevinChief Executive OfficerAug 31, 2021 Sale$36.3311,225407,763245,552Aug 31, 2021, 05:29 PM
Lee KevinChief Executive OfficerAug 27, 2021 Sale$36.021,80865,124245,085Aug 31, 2021, 05:29 PM
Kalowski LeePresident and CFOAug 27, 2021 Option Exercise$8.737,95069,4037,950Aug 27, 2021, 06:31 PM
Kalowski LeePresident and CFOAug 26, 2021 Option Exercise$8.765504,818550Aug 27, 2021, 06:31 PM
Kalowski LeePresident and CFOAug 27, 2021 Sale$35.157,950279,4430Aug 27, 2021, 06:31 PM
Kalowski LeePresident and CFOAug 26, 2021 Sale$35.0455019,2720Aug 27, 2021, 06:31 PM
Kalowski LeePresident and CFOAug 23, 2021 Option Exercise$1.607,50012,0007,500Aug 25, 2021, 05:45 PM
Kalowski LeePresident and CFOAug 23, 2021 Sale$33.027,500247,6500Aug 25, 2021, 05:45 PM
Kalowski LeePresident and CFOJul 29, 2021 Option Exercise$1.6312,50020,37512,500Jul 30, 2021, 06:21 PM
Kalowski LeePresident and CFOJul 29, 2021 Sale$31.5112,500393,8233,504Jul 30, 2021, 06:21 PM
Lee KevinChief Executive OfficerJul 26, 2021 Option Exercise$14.001001,400245,185Jul 27, 2021, 07:08 PM
Lee KevinChief Executive OfficerJul 23, 2021 Option Exercise$14.004,78266,948249,867Jul 27, 2021, 07:08 PM
Lee KevinChief Executive OfficerJul 26, 2021 Sale$36.001003,600245,085Jul 27, 2021, 07:08 PM
Lee KevinChief Executive OfficerJul 23, 2021 Sale$36.024,782172,248245,085Jul 27, 2021, 07:08 PM
BINGHAM KATEDirectorJul 13, 2021 Sale$33.501240239,625Jul 20, 2021, 04:17 PM
BINGHAM KATEDirectorJul 14, 2021 Sale$34.0143,3781,475,1821,831,671Jul 20, 2021, 04:17 PM
BINGHAM KATEDirectorJul 13, 2021 Sale$33.5058819,6981,875,049Jul 20, 2021, 04:17 PM
BINGHAM KATEDirectorJul 14, 2021 Sale$34.0191731,18538,708Jul 20, 2021, 04:17 PM
Keen NicholasChief Scientific OfficerJul 14, 2021 Sale$35.0010,000350,00018,321Jul 16, 2021, 06:27 PM
Lee KevinChief Executive OfficerJul 15, 2021 Option Exercise$14.0021,970307,580267,055Jul 16, 2021, 06:27 PM
Lee KevinChief Executive OfficerJul 16, 2021 Option Exercise$14.006098,526245,694Jul 16, 2021, 06:27 PM
Lee KevinChief Executive OfficerJul 16, 2021 Sale$34.0060920,706245,085Jul 16, 2021, 06:27 PM
Lee KevinChief Executive OfficerJul 15, 2021 Sale$34.2821,970753,132245,085Jul 16, 2021, 06:27 PM
BINGHAM KATEDirectorJul 14, 2021 Sale$34.0191731,18538,708Jul 15, 2021, 07:03 PM
BINGHAM KATEDirectorJul 13, 2021 Sale$33.501240239,625Jul 15, 2021, 07:03 PM
BINGHAM KATEDirectorJul 14, 2021 Sale$34.0143,3781,475,1821,831,671Jul 15, 2021, 07:03 PM
BINGHAM KATEDirectorJul 13, 2021 Sale$33.5058819,6981,875,049Jul 15, 2021, 07:03 PM
Crockett NigelChief Business OfficerJul 12, 2021 Option Exercise$11.727,02882,3807,028Jul 14, 2021, 06:47 PM
Crockett NigelChief Business OfficerJul 13, 2021 Option Exercise$11.8472,701860,43372,701Jul 14, 2021, 06:47 PM
Crockett NigelChief Business OfficerJul 12, 2021 Sale$32.037,028225,1070Jul 14, 2021, 06:47 PM
Crockett NigelChief Business OfficerJul 13, 2021 Sale$32.4472,7012,358,3623,121Jul 14, 2021, 06:47 PM
Lee KevinChief Executive OfficerJul 12, 2021 Option Exercise$14.001,93627,104256,670Jul 14, 2021, 06:47 PM
Lee KevinChief Executive OfficerJul 14, 2021 Option Exercise$14.008,331116,634259,550Jul 14, 2021, 06:47 PM
Lee KevinChief Executive OfficerJul 13, 2021 Option Exercise$14.0035,446496,244290,180Jul 14, 2021, 06:47 PM
Lee KevinChief Executive OfficerJul 12, 2021 Sale$32.041,93662,029254,734Jul 14, 2021, 06:47 PM
Lee KevinChief Executive OfficerJul 14, 2021 Sale$34.3414,465496,726256,908Jul 14, 2021, 06:47 PM
Lee KevinChief Executive OfficerJul 13, 2021 Sale$32.9738,9611,284,680268,201Jul 14, 2021, 06:47 PM
Crockett NigelChief Business OfficerJul 06, 2021 Option Exercise$9.822712,661271Jul 08, 2021, 05:22 PM
Crockett NigelChief Business OfficerJul 06, 2021 Sale$32.002718,6720Jul 08, 2021, 05:22 PM
Lee KevinChief Executive OfficerMay 06, 2021 Option Exercise$14.001,71624,024256,450May 10, 2021, 05:43 PM
Lee KevinChief Executive OfficerMay 07, 2021 Option Exercise$14.005,60478,456260,338May 10, 2021, 05:43 PM
Lee KevinChief Executive OfficerMay 07, 2021 Sale$32.235,604180,617254,734May 10, 2021, 05:43 PM
Lee KevinChief Executive OfficerMay 06, 2021 Sale$32.141,71655,152254,734May 10, 2021, 05:43 PM
Lee KevinChief Executive OfficerApr 27, 2021 Option Exercise$14.006,63692,904261,370Apr 28, 2021, 04:45 PM
Lee KevinChief Executive OfficerApr 26, 2021 Option Exercise$14.0014,545203,630273,345Apr 28, 2021, 04:45 PM
Lee KevinChief Executive OfficerApr 27, 2021 Sale$30.706,636203,728255,092Apr 28, 2021, 04:45 PM
Lee KevinChief Executive OfficerApr 26, 2021 Sale$31.2818,611582,144268,630Apr 28, 2021, 04:45 PM
Legault PierreDirectorApr 08, 2021 Option Exercise$8.7424,838217,08424,838Apr 09, 2021, 04:36 PM
Legault PierreDirectorApr 08, 2021 Sale$31.7124,838787,58812,338Apr 09, 2021, 04:36 PM
Legault PierreDirectorApr 05, 2021 Option Exercise$8.831621,430162Apr 07, 2021, 07:22 PM
Legault PierreDirectorApr 05, 2021 Sale$31.071625,0330Apr 07, 2021, 07:22 PM
Keen NicholasChief Scientific OfficerMar 31, 2021 Sale$30.0010,000300,00028,321Apr 02, 2021, 04:45 PM
Legault PierreDirectorMar 31, 2021 Option Exercise$8.7810,00087,80010,000Apr 02, 2021, 04:44 PM
Legault PierreDirectorMar 31, 2021 Sale$30.0010,000300,0000Apr 02, 2021, 04:44 PM
Legault PierreDirectorMar 17, 2021 Option Exercise$8.857,78468,8887,784Mar 19, 2021, 04:48 PM
Legault PierreDirectorMar 17, 2021 Sale$29.007,784225,7360Mar 19, 2021, 04:48 PM
Legault PierreDirectorMar 12, 2021 Option Exercise$8.862,21619,6342,216Mar 16, 2021, 07:42 PM
Legault PierreDirectorMar 12, 2021 Sale$29.002,21664,2640Mar 16, 2021, 07:42 PM
Keen NicholasChief Scientific OfficerMar 15, 2021 Sale$28.002176,07638,321Mar 16, 2021, 07:41 PM
Keen NicholasChief Scientific OfficerMar 12, 2021 Sale$28.509,783278,76738,821Mar 16, 2021, 07:41 PM
Lee KevinChief Executive OfficerFeb 05, 2021 Sale$31.001003,100258,800Feb 09, 2021, 05:28 PM
Lee KevinChief Executive OfficerJan 20, 2021 Sale$31.881,18537,779259,351Jan 21, 2021, 04:34 PM
Lee KevinChief Executive OfficerJan 19, 2021 Sale$29.265,000146,290260,556Jan 21, 2021, 04:34 PM
Kalowski LeePresident and CFOJan 19, 2021 Option Exercise$1.5915,00023,85015,000Jan 21, 2021, 04:29 PM
Kalowski LeePresident and CFOJan 19, 2021 Sale$30.0015,000450,0000Jan 21, 2021, 04:29 PM
Kalowski LeePresident and CFOJan 14, 2021 Option Exercise$1.6010,00016,00010,000Jan 15, 2021, 04:44 PM
Kalowski LeePresident and CFOJan 14, 2021 Sale$25.0010,000250,0000Jan 15, 2021, 04:44 PM
Lee KevinChief Executive OfficerJan 15, 2021 Sale$27.015,000135,050265,085Jan 15, 2021, 04:40 PM
Lee KevinChief Executive OfficerJan 14, 2021 Sale$25.005,000125,000270,085Jan 15, 2021, 04:40 PM
Kalowski LeePresident and CFODec 01, 2020 Option Exercise$1.567,50011,7007,500Dec 03, 2020, 08:53 PM
Kalowski LeePresident and CFODec 01, 2020 Sale$22.507,500168,7500Dec 03, 2020, 08:53 PM
Kalowski LeePresident and CFONov 27, 2020 Option Exercise$1.56530827530Nov 30, 2020, 04:42 PM
Kalowski LeePresident and CFONov 27, 2020 Sale$20.0053010,6000Nov 30, 2020, 04:42 PM
Kalowski LeePresident and CFONov 25, 2020 Option Exercise$1.569,78115,2589,781Nov 25, 2020, 08:31 PM
Kalowski LeePresident and CFONov 23, 2020 Option Exercise$1.5617,18926,81517,189Nov 25, 2020, 08:31 PM
Kalowski LeePresident and CFONov 23, 2020 Sale$19.8317,189340,805213Nov 25, 2020, 08:31 PM
Kalowski LeePresident and CFONov 25, 2020 Sale$20.079,781196,3050Nov 25, 2020, 08:31 PM
GLAXOSMITHKLINE PLC10% OwnerJul 15, 2020 Sale$19.403,14761,0451,910,609Sep 18, 2020, 12:04 PM
GLAXOSMITHKLINE PLC10% OwnerJul 14, 2020 Sale$19.271,59730,7811,913,678Sep 18, 2020, 12:04 PM
TYBOURNE CAPITAL MANAGEMENT (HK) LTD10% OwnerMay 28, 2019 Buy$14.00364,2865,100,0041,957,961Jun 03, 2019, 05:15 PM
Cambridge Innovation Capital (Jersey) Ltd10% OwnerMay 29, 2019 Buy$14.00314,2864,400,0041,751,437May 31, 2019, 05:12 PM
Novartis Bioventures Ltd10% OwnerMay 28, 2019 Buy$14.00168,6302,360,8201,769,641May 30, 2019, 09:27 PM
NG CAROLYNDirectorMay 27, 2019 Buy$14.00571,4298,000,006571,429May 30, 2019, 09:27 PM
SVLSF V, LLC10% OwnerMay 28, 2019 Buy$14.007,983111,76239,637May 30, 2019, 09:26 PM
SVLSF V, LLC10% OwnerMay 28, 2019 Buy$14.00377,7325,288,2481,875,637May 30, 2019, 09:26 PM
Anstey MichaelDirectorMay 28, 2019 Buy$14.00314,2864,400,0041,751,437May 30, 2019, 09:26 PM
BINGHAM KATEDirectorMay 28, 2019 Buy$14.00377,7325,288,2481,875,637May 30, 2019, 09:26 PM
BINGHAM KATEDirectorMay 28, 2019 Buy$14.007,983111,76239,637May 30, 2019, 09:26 PM
HARLAND DEBORAHDirectorMay 28, 2019 Buy$14.00385,7145,399,9961,915,275May 30, 2019, 09:25 PM
GLAXOSMITHKLINE PLCDirectorMay 28, 2019 Buy$14.00385,7145,399,9961,915,275May 30, 2019, 05:47 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFF04/11/20245,780
Lee KevinCHIEF EXECUTIVE OFFICER04/03/202475,192
Skynner MichaelCHIEF TECHNOLOGY OFFICER04/03/202422,739
Milnes AlistairCHIEF OPERATING OFFICER04/03/202422,739
Keen NicholasCHIEF SCIENTIFIC OFFICER04/03/202418,810
Crockett NigelCHIEF BUSINESS OFFICER04/03/202422,739
Thompson Travis AlvinCHIEF ACCOUNTING OFFICER04/03/20243,619
Thompson Travis AlvinChief Accounting Officer01/03/202410,570
Keen NicholasChief Scientific Officer01/03/202446,200
Crockett NigelChief Business Officer01/03/202446,253
Milnes AlistairChief Operating Officer01/03/202446,253
Skynner MichaelChief Technology Officer01/03/202446,253
Lee KevinChief Executive Officer01/03/2024152,303
Thompson Travis AlvinChief Accounting Officer10/03/20231,080
Keen NicholasChief Scientific Officer10/03/20235,440
Crockett NigelChief Business Officer10/03/20238,840
Milnes AlistairChief Operating Officer10/03/20238,840
Lee KevinChief Executive Officer10/03/202329,400
Skynner MichaelChief Technology Officer10/03/20238,840
Thompson Travis AlvinChief Accounting Officer07/03/20231,531
Skynner MichaelChief Technology Officer07/03/202311,320
Milnes AlistairChief Operating Officer07/03/202311,320
Lee KevinChief Executive Officer07/03/202337,600
Keen NicholasChief Scientific Officer07/03/20238,434
Crockett NigelChief Business Officer07/03/202311,320
Keen NicholasChief Scientific Officer04/03/20236,734
Skynner MichaelChief Technology Officer04/03/20239,436
Milnes AlistairChief Operating Officer04/03/20239,436
Kalowski LeePresident and CFO04/03/20237,937
Crockett NigelChief Business Officer04/03/20239,436
Lee KevinChief Executive Officer04/03/202331,369
Crockett NigelChief Business Officer01/03/202352,337
Milnes AlistairChief Operating Officer01/03/202352,337
Smethurst DominicChief Medical Officer01/03/202352,337
Skynner MichaelChief Technology Officer01/03/202352,337
Keen NicholasChief Scientific Officer01/03/202352,802
Kalowski LeePresident and CFO01/03/202352,744
Lee KevinChief Executive Officer01/03/2023174,360
Milnes AlistairChief Operating Officer03/25/2022103,719
Keen NicholasChief Scientific Officer12/21/2021216,678
Legault PierreDirector12/22/2021829,853
Legault PierreDirector12/21/2021375,892
Legault PierreDirector12/20/202163,941
Legault PierreDirector12/21/20212,543,508
Legault PierreDirector12/20/2021433,523
Legault PierreDirector12/22/20215,676,858
Lee KevinChief Executive Officer10/18/20212,940
Lee KevinChief Executive Officer10/15/202119,216
Lee KevinChief Executive Officer10/14/2021277,860
Lee KevinChief Executive Officer10/11/2021269,388
Keen NicholasChief Scientific Officer10/05/202198,228
Keen NicholasChief Scientific Officer10/01/202153,460
Smethurst DominicChief Medical Officer09/23/2021111,300
Keen NicholasChief Scientific Officer09/16/202187,995
Keen NicholasChief Scientific Officer09/15/2021135,000
Kalowski LeePresident and CFO09/02/202198,200
Kalowski LeePresident and CFO09/02/2021400,000
Keen NicholasChief Scientific Officer09/02/2021400,000
Lee KevinChief Executive Officer09/01/2021320,460
Lee KevinChief Executive Officer09/01/20211,007,897
Lee KevinChief Executive Officer09/02/2021200,000
Lee KevinChief Executive Officer08/31/2021145,880
Lee KevinChief Executive Officer08/27/202125,312
Lee KevinChief Executive Officer08/31/2021407,763
Lee KevinChief Executive Officer08/27/202165,124
Kalowski LeePresident and CFO08/27/202169,403
Kalowski LeePresident and CFO08/26/20214,818
Kalowski LeePresident and CFO08/27/2021279,443
Kalowski LeePresident and CFO08/26/202119,272
Kalowski LeePresident and CFO08/23/202112,000
Kalowski LeePresident and CFO08/23/2021247,650
Kalowski LeePresident and CFO07/29/202120,375
Kalowski LeePresident and CFO07/29/2021393,823
Lee KevinChief Executive Officer07/26/20211,400
Lee KevinChief Executive Officer07/23/202166,948
Lee KevinChief Executive Officer07/26/20213,600
Lee KevinChief Executive Officer07/23/2021172,248
BINGHAM KATEDirector07/13/2021402
BINGHAM KATEDirector07/14/20211,475,182
BINGHAM KATEDirector07/13/202119,698
BINGHAM KATEDirector07/14/202131,185
Keen NicholasChief Scientific Officer07/14/2021350,000
Lee KevinChief Executive Officer07/15/2021307,580
Lee KevinChief Executive Officer07/16/20218,526
Lee KevinChief Executive Officer07/16/202120,706
Lee KevinChief Executive Officer07/15/2021753,132
BINGHAM KATEDirector07/14/202131,185
BINGHAM KATEDirector07/13/2021402
BINGHAM KATEDirector07/14/20211,475,182
BINGHAM KATEDirector07/13/202119,698
Crockett NigelChief Business Officer07/12/202182,380
Crockett NigelChief Business Officer07/13/2021860,433
Crockett NigelChief Business Officer07/12/2021225,107
Crockett NigelChief Business Officer07/13/20212,358,362
Lee KevinChief Executive Officer07/12/202127,104
Lee KevinChief Executive Officer07/14/2021116,634
Lee KevinChief Executive Officer07/13/2021496,244
Lee KevinChief Executive Officer07/12/202162,029
Lee KevinChief Executive Officer07/14/2021496,726
Lee KevinChief Executive Officer07/13/20211,284,680
Crockett NigelChief Business Officer07/06/20212,661
Crockett NigelChief Business Officer07/06/20218,672
Lee KevinChief Executive Officer05/06/202124,024
Lee KevinChief Executive Officer05/07/202178,456
Lee KevinChief Executive Officer05/07/2021180,617
Lee KevinChief Executive Officer05/06/202155,152
Lee KevinChief Executive Officer04/27/202192,904
Lee KevinChief Executive Officer04/26/2021203,630
Lee KevinChief Executive Officer04/27/2021203,728
Lee KevinChief Executive Officer04/26/2021582,144
Legault PierreDirector04/08/2021217,084
Legault PierreDirector04/08/2021787,588
Legault PierreDirector04/05/20211,430
Legault PierreDirector04/05/20215,033
Keen NicholasChief Scientific Officer03/31/2021300,000
Legault PierreDirector03/31/202187,800
Legault PierreDirector03/31/2021300,000
Legault PierreDirector03/17/202168,888
Legault PierreDirector03/17/2021225,736
Legault PierreDirector03/12/202119,634
Legault PierreDirector03/12/202164,264
Keen NicholasChief Scientific Officer03/15/20216,076
Keen NicholasChief Scientific Officer03/12/2021278,767
Lee KevinChief Executive Officer02/05/20213,100
Lee KevinChief Executive Officer01/20/202137,779
Lee KevinChief Executive Officer01/19/2021146,290
Kalowski LeePresident and CFO01/19/202123,850
Kalowski LeePresident and CFO01/19/2021450,000
Kalowski LeePresident and CFO01/14/202116,000
Kalowski LeePresident and CFO01/14/2021250,000
Lee KevinChief Executive Officer01/15/2021135,050
Lee KevinChief Executive Officer01/14/2021125,000
Kalowski LeePresident and CFO12/01/202011,700
Kalowski LeePresident and CFO12/01/2020168,750
Kalowski LeePresident and CFO11/27/2020827
Kalowski LeePresident and CFO11/27/202010,600
Kalowski LeePresident and CFO11/25/202015,258
Kalowski LeePresident and CFO11/23/202026,815
Kalowski LeePresident and CFO11/23/2020340,805
Kalowski LeePresident and CFO11/25/2020196,305
GLAXOSMITHKLINE PLC10% Owner07/15/202061,045
GLAXOSMITHKLINE PLC10% Owner07/14/202030,781
TYBOURNE CAPITAL MANAGEMENT (HK) LTD10% Owner05/28/20195,100,004
Cambridge Innovation Capital (Jersey) Ltd10% Owner05/29/20194,400,004
Novartis Bioventures Ltd10% Owner05/28/20192,360,820
NG CAROLYNDirector05/27/20198,000,006
SVLSF V, LLC10% Owner05/28/2019111,762
SVLSF V, LLC10% Owner05/28/20195,288,248
Anstey MichaelDirector05/28/20194,400,004
BINGHAM KATEDirector05/28/20195,288,248
BINGHAM KATEDirector05/28/2019111,762
HARLAND DEBORAHDirector05/28/20195,399,996
GLAXOSMITHKLINE PLCDirector05/28/20195,399,996
Load More Insider Transactions
FUNDS WITH A POSITION IN BICYCLE THERAPEUTICS PLC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BAKER BROS. ADVISORS LP4,823,5980.96%169.42%Other
TYBOURNE CAPITAL MANAGEMENT (HK) LTD1,650,3204.45%28.75%Growth, Growth At A Reasonable Price
SUVRETTA CAPITAL MANAGEMENT, LLC914,4760.75%-9.55%Growth At A Reasonable Price
CANDRIAM S.C.A.869,2580.11%-30.64%Other
RA CAPITAL MANAGEMENT, L.P.800,0000.23%No changeOther
BLACKROCK INC.501,6230.00023%158.46%Other
PLATINUM INVESTMENT MANAGEMENT LTD362,0800.27%26.83%Growth At A Reasonable Price, Value
UBS OCONNOR LLC125,000 (Call)0.02%431.91%Value
RENAISSANCE TECHNOLOGIES LLC105,5000.00295%28.66%Other
UBS OCONNOR LLC73,6010.1%-5.52%Value
GEODE CAPITAL MANAGEMENT, LLC18,8370.00004%9.88%Other
CHANGE IN SHARES OUTSTANDING FOR BICYCLE THERAPEUTICS PLC
STOCK BUYBACKS FOR BICYCLE THERAPEUTICS PLC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
7.37%
1Q
12/31/2023
12/31/2022
43.02%
4Q
12/31/2023
09/30/2022
43.19%
5Q
12/31/2023
06/30/2022
43.33%
6Q
12/31/2023
03/31/2022
43.54%
7Q
12/31/2023
12/31/2021
46.08%
8Q
12/31/2023
09/30/2021
69.71%
9Q
12/31/2023
06/30/2021
76.68%
10Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
7.37%
1Q
12/31/2022
43.02%
4Q
09/30/2022
43.19%
5Q
06/30/2022
43.33%
6Q
03/31/2022
43.54%
7Q
12/31/2021
46.08%
8Q
09/30/2021
69.71%
9Q
06/30/2021
76.68%
10Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR BICYCLE THERAPEUTICS PLC
LOADING...